ABSTRACT
The aim of this study was to assess the association of vitamin B12 level and single nucleotide polymorphisms (SNPs) in vitamin B12 metabolic genes with pulmonary tuberculosis (PTB) in Chinese Han population. The plasma vitamin B12 expression level was detected using ELISA. Ten SNPs in six key genes (TCN1, TCN2, CUBN, MMACHC, FUT6, and MUT) of vitamin B12 metabolic pathway were included for genotyping by the SNPscan technique among 454 PTB patients and 467 controls. Our results found that vitamin B12 level was significantly reduced in PTB patients when compared with controls. There was no significant association between TCN1 rs526934, TCN2 rs1801198, CUBN rs7906242, rs10904861, rs1801222, MMACHC rs10789465, FUT6 rs3760776, rs3760775, MUT rs9473555, rs9381784 variants, and PTB susceptibility. TCN2 rs1801198 CC genotype, C allele was significantly associated with hypoproteinemia in PTB patients. In CUBN, rs7906242 GG genotype, G allele, rs10904861 TT genotype, and T allele were significantly related to the decreased frequency of sputum smear-positive, and rs10904861 variant affected the occurrence of drug resistance in PTB patients. In addition, the increased frequency of CUBN rs1801222 AA genotype was significantly associated with leukopenia. The decreased frequency of MUT rs9473555 CC genotype was found in the PTB patients with hypoproteinemia. However, vitamin B12 expression was not associated with the genotype distribution of above SNPs. In conclusion, vitamin B12 level was significantly decreased in PTB patients and genetic variants in vitamin B12 metabolic genes were not contributed to PTB susceptibility. Several SNPs in TCN2, CUBN, and MUT gene might associate with multiple clinical manifestations in PTB.
Subject(s)
Hypoproteinemia , Tuberculosis, Pulmonary , Humans , Vitamin B 12/metabolism , Alleles , Polymorphism, Single Nucleotide , Tuberculosis, Pulmonary/genetics , Hypoproteinemia/genetics , Oxidoreductases/geneticsABSTRACT
Complement hyperactivation, angiopathic thrombosis and protein-losing enteropathy (CHAPLE disease) is a lethal disease caused by genetic loss of the complement regulatory protein CD55, leading to overactivation of complement and innate immunity together with immunodeficiency due to immunoglobulin wasting in the intestine. We report in vivo human data accumulated using the complement C5 inhibitor eculizumab for the medical treatment of patients with CHAPLE disease. We observed cessation of gastrointestinal pathology together with restoration of normal immunity and metabolism. We found that patients rapidly renormalized immunoglobulin concentrations and other serum proteins as revealed by aptamer profiling, re-established a healthy gut microbiome, discontinued immunoglobulin replacement and other treatments and exhibited catch-up growth. Thus, we show that blockade of C5 by eculizumab effectively re-establishes regulation of the innate immune complement system to substantially reduce the pathophysiological manifestations of CD55 deficiency in humans.
Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Complement Activation/drug effects , Complement C5/antagonists & inhibitors , Complement Inactivating Agents/therapeutic use , Energy Metabolism/drug effects , Hypoproteinemia/drug therapy , Immunity, Innate/drug effects , Protein-Losing Enteropathies/drug therapy , Antibodies, Monoclonal, Humanized/adverse effects , Antibodies, Monoclonal, Humanized/pharmacokinetics , Biomarkers/blood , CD55 Antigens/deficiency , CD55 Antigens/genetics , Complement C5/metabolism , Complement Inactivating Agents/adverse effects , Complement Inactivating Agents/pharmacokinetics , Genetic Predisposition to Disease , Humans , Hypoproteinemia/genetics , Hypoproteinemia/immunology , Hypoproteinemia/metabolism , Mutation , Phenotype , Protein-Losing Enteropathies/genetics , Protein-Losing Enteropathies/immunology , Protein-Losing Enteropathies/metabolism , Treatment OutcomeABSTRACT
No disponible
Subject(s)
Humans , Female , Infant, Newborn , Abnormalities, Multiple/genetics , Eye Abnormalities/genetics , Laminin/genetics , Mutagenesis/genetics , Consanguinity , Renal Insufficiency/complications , Abnormalities, Multiple/pathology , Abnormalities, Multiple/mortality , Ketosis/blood , Ketosis/genetics , Hypoproteinemia/genetics , Creatinine/analysis , White MatterABSTRACT
Congenital nephrotic syndrome of the Finnish type is a serious renal disease belonging to the Finnish disease heritage. It appears as substantial proteinuria, hypoproteinemia and edema in a newborn. Kidney transplantation is the only effective treatment. The cause of the disease is a mutation in the gene encoding the nephrin protein. Nephrin is produced by the epithelial cell (podocyte) of the glomerulus. It is expressed in the slit membrane connecting the pedicles of the podocyte. This finding has revolutionized the concept of glomerular filtration and set off active research on the pathogenetic mechanisms of proteinuria.
Subject(s)
Nephrotic Syndrome/congenital , Edema/congenital , Edema/genetics , Finland/epidemiology , Genotype , Glomerular Filtration Rate , Humans , Hypoproteinemia/congenital , Hypoproteinemia/genetics , Infant, Newborn , Kidney Transplantation , Membrane Proteins/genetics , Mutation , Nephrotic Syndrome/genetics , Proteinuria/congenital , Proteinuria/geneticsABSTRACT
A 70-year-old woman with yellow nail syndrome and right-sided pleural effusion, lower extremity edema, and hypoalbuminemia was followed for 18 months. She reported an 8-year history of asthma. She had four children (3 boys and 1 girl). Dystrophy, changes in color and shape of nails both hands and foot, along with lower extremity edema was observed in the daughter and two of her sons. One son had asthma. The patient reported that her grandmother had similar nail abnormality and lower extremity edema. Other family members and patient's grandchildren were healthy. This report demonstrates a case of familial yellow-nail syndrome.
Subject(s)
Hypoproteinemia/genetics , Lymphedema/genetics , Nail Diseases/genetics , Pleural Effusion/genetics , Aged , Female , Humans , Pigmentation Disorders/genetics , SyndromeABSTRACT
Two siblings, products of a consanguineous marriage, were markedly deficient in both albumin and IgG because of rapid degradation of these proteins, suggesting a lack of the neonatal Fc receptor, FcRn. FcRn is a heterodimeric receptor composed of a nonclassical MHC class I alpha-chain and beta(2)-microglobulin (beta(2)m) that binds two ligands, IgG and albumin, and extends the catabolic half-lives of both. Eight relatives of the siblings were moderately IgG-deficient. From sera archived for 35 years, we sequenced the two siblings' genes for the heterodimeric FcRn. We found that, although the alpha-chain gene sequences of the siblings were normal, the beta(2)m genes contained a single nucleotide transversion that would mutate a conserved alanine to proline at the midpoint of the signal sequence. Concentrations of soluble beta(2)m and HLA in the siblings' sera were <1% of normal. Transfection assays of beta(2)m-deficient cultured cells with beta(2)m cDNA indicated that the mutant beta(2)m supported <20% of normal expression of beta(2)m, MHC class I, and FcRn proteins. We concluded that a beta(2)m gene mutation underlies the hypercatabolism and reduced serum levels of albumin and IgG in the two siblings with familial hypercatabolic hypoproteinemia. This experiment of nature affirms our hypothesis that FcRn binds IgG and albumin, salvages both from a degradative fate, and maintains their physiologic concentrations.
Subject(s)
Histocompatibility Antigens Class I/metabolism , Hypoproteinemia/genetics , Hypoproteinemia/metabolism , Receptors, Fc/deficiency , Receptors, Fc/metabolism , beta 2-Microglobulin/genetics , beta 2-Microglobulin/metabolism , Amino Acid Sequence , Base Sequence , Cell Line, Tumor , Disease Susceptibility , Gene Expression Regulation , Histocompatibility Antigens Class I/genetics , Humans , Hypoproteinemia/pathology , Molecular Sequence Data , Mutation/genetics , Receptors, Fc/genetics , beta 2-Microglobulin/chemistryABSTRACT
Menetrier's disease is characterized by giant gastric folds with foveolar hyperplasia and cystic dilatation, hypoproteinemia, and enhanced mucus secretion. The etiology remains unresolved and an effective treatment has yet to be established. Here we show that histamine H(2)-receptor deficient mice developed gastric pathophysiological changes resembling Menetrier's disease for up to 17 months of observation. Mutant mice were found to have an increased stomach weight, enlarged gastric folds with cystic dilatation, hypergastrinemia, hypoalbuminemia, increased mucus secretion and overexpression of mucosal transforming growth factor (TGF) alpha. Both a cholecystokinin (CCK)(2)-receptor antagonist and an epidermal growth factor (EGF)-receptor tyrosine kinase inhibitor significantly reduced the increase in stomach weight. It appears that lack or downregulation of histamine H(2)-receptors might be involved in the pathogenesis of Menetrier's disease.
Subject(s)
Receptors, Histamine H2/physiology , Stomach Diseases/physiopathology , Stomach/physiology , Animals , Body Weight/physiology , Gastric Mucosa/metabolism , Gastric Mucosa/pathology , Gastric Mucosa/physiopathology , Gastrins/blood , Hydrogen-Ion Concentration , Hyperplasia/genetics , Hyperplasia/pathology , Hyperplasia/physiopathology , Hypoproteinemia/genetics , Hypoproteinemia/pathology , Hypoproteinemia/physiopathology , Immunohistochemistry , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mucus/metabolism , Organ Size/physiology , Phenotype , Receptors, Histamine H2/genetics , Serum Albumin/metabolism , Stomach Diseases/genetics , Stomach Diseases/pathology , SyndromeABSTRACT
BACKGROUND: Congenital nephrotic syndrome (NPHS1) is a rare disease inherited as an autosomally recessive trait. The NPHS1 gene mutated in NPHS1 children has recently been identified. The gene codes for nephrin, a cell-surface protein of podocytes. Two mutations, named Fin-major and Fin-minor, have been found in over 90% of the Finnish patients. In this study, we correlated the NPHS1 gene mutations to the clinical features and renal findings in 46 Finnish NPHS1 children. METHODS: Clinical data were collected from patient files, and kidney histology and electron microscopy samples were re-evaluated. The expression of nephrin was studied using immunohistochemistry, Western blotting, and in situ hybridization. RESULTS: Nephrotic syndrome was detected in most patients within days after birth regardless of the genotype detected. No difference could be found in neonatal, renal, cardiac, or neurological features in patients with different mutations. Nephrin was not expressed in kidneys with Fin-major or Fin-minor mutations, while another slit diaphragm-associated protein, ZO-1, stained normally. In electron microscopy, podocyte fusion and podocyte filtration slits of various sizes were detected. The slit diaphragms, however, were missing. In contrast to this, a nephrotic infant with Fin-major/R743C genotype expressed nephrin in kidney had normal slit diaphragms and responded to therapy with an angiotensin-converting enzyme inhibitor and indomethacin. CONCLUSIONS: The most common NPHS1 gene mutations, Fin-major and Fin-minor, both lead to an absence of nephrin and podocyte slit diaphragms, as well as a clinically severe form of NPHS1, the Finnish type of congenital nephrotic syndrome.
Subject(s)
Mutation, Missense , Nephrotic Syndrome/genetics , Proteins/genetics , Blotting, Western , Finland , Gene Expression , Genes, Recessive , Genotype , Humans , Hypoproteinemia/congenital , Hypoproteinemia/genetics , In Situ Hybridization , Infant, Newborn , Kidney/chemistry , Kidney/ultrastructure , Membrane Proteins/analysis , Membrane Proteins/genetics , Microscopy, Electron , Nephrotic Syndrome/congenital , Phosphoproteins/analysis , Phosphoproteins/genetics , Proteins/analysis , Proteinuria/congenital , Proteinuria/genetics , RNA, Messenger/analysis , Zonula Occludens-1 ProteinABSTRACT
The T4-binding globulin (TBG) gene is a single copy located on the X-chromosome. Previous studies have failed to elucidate the molecular defect in individuals with complete TBG deficiency (TBG-CD). Indeed, no major deletions, insertions, or other rearrangements were observed in the TBG gene of six unrelated males with this defect. To clarify the molecular basis of TBG-CD, we have cloned and sequenced the TBG gene of an affected male (CD5) of French Canadian origin. The sequence of the exons encoding the mature protein, adjacent introns, and the promoter region revealed two nucleotide substitutions: CTA(Leu)----CCA(Pro) at codon 227 and TTG(Leu)----TTT(Phe) at codon 283. The Leu----Phe substitution, a relatively conservative replacement, is a TBG polymorphism present in 16% (3 of 19) of French Canadian males. It has no effect on the serum concentration or properties of the common type TBG (TBG-C). The new Leu----Pro substitution, which is predicted to alter the higher order of TBG structure, is probably responsible for the TBG-CD phenotype of the individual studied and two other families with TBG-CD. It possibly impairs TBG biosynthesis or secretion or perhaps alters TBG structure to such a degree that the molecule is not recognized by antibodies against native or denatured TBG and does not bind T4.
Subject(s)
Hypoproteinemia/genetics , Leucine , Proline , Thyroxine-Binding Proteins/genetics , Adult , Amino Acid Sequence , Base Sequence , Binding Sites , Cloning, Molecular , Codon/analysis , DNA/analysis , DNA Restriction Enzymes , Exons , Family , Gene Amplification , Genes , Humans , Leucine/analysis , Male , Molecular Sequence Data , Proline/analysis , Promoter Regions, Genetic , Racial Groups , Thyronines/blood , Thyroxine-Binding Proteins/analysis , Thyroxine-Binding Proteins/deficiencyABSTRACT
Retinol-binding protein (RBP), a plasma protein with a molecular weight of 21,000 daltons, binds to retinol with a 1:1 molar ratio and transports it to the peripheral tissues. Familial hypo-retinol-binding proteinemia (hypo-RBPnemia) was detected in a 2-year-old girl who developed keratomalacia, and in her mother and sister. They persistently showed half the normal levels of RBP and retinol. Restriction fragments of leukocyte DNA, created by digestion with BamHI, EcoRI and PstI when human RBP complementary DNA was used as a probe, showed the same patterns in both the affected and unaffected family members. These results indicate that familial hypo-RBPnemia could be attributed to such minor changes as point mutations, rather than large deletion or insertion in the RBP gene.
Subject(s)
Hypoproteinemia/genetics , Retinol-Binding Proteins/genetics , Blotting, Southern , Child, Preschool , Chromosome Mapping , DNA/isolation & purification , DNA/metabolism , DNA Probes , Female , Humans , Leukocytes , Male , Polymorphism, Restriction Fragment Length , Retinol-Binding Proteins, Plasma , Vitamin A/geneticsSubject(s)
Peutz-Jeghers Syndrome/genetics , Adolescent , Alopecia/genetics , Diarrhea/genetics , Humans , Hypoproteinemia/genetics , Male , Nail Diseases/genetics , PedigreeABSTRACT
We reported previously familial hypo-retinol-binding proteinemia in a child who developed keratomalacia during measles infection. In the present study, we characterized serum retinol-binding proteins (RBPs) in the affected family members and compared these RBPs with those in the unaffected family members. Immunoblotting following SDS-polyacrylamide gel electrophoresis and isoelectric focusing demonstrated no differences in molecular weight and isoelectric point between the RBPs from the affected and unaffected family members, as far as RBPs were detected by antibody against standard RBP. Gel filtration revealed that all the RBPs in the serum of the affected family members made a complex with prealbumin.
Subject(s)
Corneal Diseases/complications , Hypoproteinemia/genetics , Retinol-Binding Proteins/deficiency , Vitamin A Deficiency/complications , Blotting, Western , Chromatography, Gel , Electrophoresis, Polyacrylamide Gel , Female , Humans , Isoelectric Focusing , Male , Measles/complications , Pedigree , Retinol-Binding Proteins/analysis , Retinol-Binding Proteins/immunology , Vitamin A Deficiency/geneticsABSTRACT
A congenital deficiency in protein C (physiological inhibitor of coagulation) was identified in 57 patients: the deficiency was quantitative (type I) in 20 families, qualitative (type II) in two families. The transmission was autosomal dominant in 21 families but was suspected to be recessive in one family: the 18 years old homozygous propositus has a severe deficiency (protein C = 16 p. 100): both parents are heterozygous (consanguinity was present) and 5 other family members with heterozygous deficiency are asymptomatic. In the 49 patients (25 women, 24 men) belonging to the 21 other families, 9 men and 4 women (27 p.100) are asymptomatic although precipitating factors had existed in 5 patients. In the remaining 36 symptomatic patients, a deep venous thrombosis was observed in 34, a pulmonary embolism in 18. Recurrent arterial thromboses were diagnosed in 3 patients. The first thrombotic episode was observed at the mean age of 27 +/- 11 years and a triggering factor was found in 26 patients (72 p. 100). Thrombosis was recurrent in 21 (60 p. 100). In the patients without oral anticoagulant treatment, mean protein C antigen concentrations were 47 +/- 9 p. 100 and mean protein C activity was 46 +/- 10 p. 100. In 4 patients with type II deficiency, protein C antigen levels were normal (113 +/- 15 p. 100), contrasting with decreased protein C activity (43 +/- 6 p. 100). Thirty-eight patients have been treated with oral anticoagulants and a skin necrosis developed in the homozygous patients only.(ABSTRACT TRUNCATED AT 250 WORDS)
Subject(s)
Protein C Deficiency , Adolescent , Adult , Anticoagulants/therapeutic use , Child , Child, Preschool , Female , Humans , Hypoproteinemia/genetics , Male , Pedigree , Recurrence , Thromboembolism/drug therapy , Thromboembolism/etiology , Vitamin K/antagonists & inhibitorsABSTRACT
Serum ceruloplasmin values of less than 21.0 mg/100 ml in males or less than 23.0 mg/100 ml in females were observed in 14 out of 156 otherwise healthy members of a pedigree. The hypoceruloplasminemia segregated in a fashion suggesting that the affected individuals are heterozygous for a mutant gene that results in hypoceruloplasminemia. This mutant gene could be a Wilson's disease gene, but excessive copper loading was absent. It is suggested that hereditary hypoceruloplasminemia may be a benign entity distinct from Wilson's disease.
Subject(s)
Ceruloplasmin/deficiency , Metal Metabolism, Inborn Errors/genetics , Adolescent , Adult , Aged , Ceruloplasmin/genetics , Child , Child, Preschool , Copper/metabolism , Female , Genes , Hepatolenticular Degeneration/genetics , Heterozygote , Humans , Hypoproteinemia/genetics , Male , Mutation , PedigreeSubject(s)
Anemia/genetics , Cystic Fibrosis/genetics , Diseases in Twins , Hypoproteinemia/genetics , Anemia/complications , Cystic Fibrosis/complications , Female , Humans , Hypoproteinemia/complications , Infant , Infant Nutritional Physiological Phenomena , Milk Proteins , Pregnancy , Twins, MonozygoticABSTRACT
Hypolipidemias can be divided in primary, familial and hereditary forms and symptomatic forms which may accompany other diseases. The primary hypolipidemias (abetalipoproteinemia, hypobetalipoproteinemia and analphalipoproteinemia) are very rare. Severe hypolipidemia can be found in some peoples (e.g. the Masai). This article is chiefly devoted to secondary hypolipidemias such as those associated with malabsorption, malnutrition and maldigestion including protein-losing gastroenteropathy, with liver diseases, endocrine diseases (hyperthyroidism, hirsutism) and anemia. Finally, the hypolipidemias secondary to the formation of autoantibodies against HDL and LDL in M-gradient, carcinoma and rheumatoid arthritis are briefly reviewed.
Subject(s)
Lipoproteins/deficiency , Abetalipoproteinemia/diagnosis , Anemia/complications , Autoantibodies/analysis , Cholesterol/blood , Deficiency Diseases/classification , Deficiency Diseases/diagnosis , Hirsutism/complications , Humans , Hyperthyroidism/complications , Hyperthyroidism/metabolism , Hypoproteinemia/etiology , Hypoproteinemia/genetics , Infections/complications , Lipoproteins/blood , Lipoproteins/immunology , Lipoproteins, HDL/blood , Lipoproteins, LDL/blood , Liver Diseases/complications , Malabsorption Syndromes/complications , Neoplasms/blood , Protein-Losing Enteropathies/complicationsABSTRACT
A new case of abetalipoproteinemia (ABL) is reported after its recognition during an acquired hemorrhagic disthesis at parturition in a 37-year-old female. The new born infant of that delivery and 4 other first-degree relatives were subsequently studied and found to have hypobetalipoproteinemia (HBL). ABL and HBL, while sharing many clinical and biochemical similarities have, but rarely, been demonstrated within the same kindred and have, therefore, been regarded as different genetic mutations. Analysis of the data in the present and two other reported families indicates that ABL can result from the homozygous inheritance of the same gene which, when present in the heterozygous state, results in HBL't is concluded, therefore, that these cases of ABL have apparently been inherited via a different genetic mutation than most previously reported cases of ABL,and is likely the same gene involved in HBL. The clinical presentation of this form of ABL, that is, familial homozygous hypobetalipoproteinemia, is compared to that of the classical form of ABL.